Investor Relations Contacts

Key Facts

Latest Aide Memoire

AstraZeneca at a glance



Upcoming events

Full-Year 2019 Results

Full-Year 2019 Investor Roadshows – Amsterdam, Brussels, Edinburgh, Frankfurt, London, Milan, Paris, Stockholm, Zurich, Boston, Chicago, Denver, Los Angeles, Montreal, New York, San Francisco and Toronto

SVB Leerink conference (NYC, NY)

Second interim dividend ex-dividend date

Second interim dividend record date


Annual Reports

 


Investor enquiries

Main Contacts

Thomas Kudsk Larsen

Henry Wheeler

Oncology

Josie Afolabi

BioPharmaceuticals (Respiratory)

Craig Marks

Finance, fixed income

Christer Gruvris

BioPharmaceuticals (CV, Metabolism)

Tom Waldron

Other medicines

Jennifer Kretzmann

Corporate access, retail investors

Nick Stone

BioPharmaceuticals (Renal), ESG

US general enquiries


  • Shareholder information

    Please find relevant shareholder information and shareholder tools on this page


  • Shareholder FAQs

    Answers to frequently asked shareholder questions


  • Governance

    We apply the principles of good corporate governance in the UK Corporate Governance Code and related guidance